(RTTNews) - Novocure (NVCR) announced the FDA approved new Head Flexible Electrode transducer arrays for use with Optune Gio for the treatment of adult patients with glioblastoma multiforme. Novocure ...

(RTTNews) - Novocure (NVCR) an oncology company, has received approval from the FDA for its new Head Flexible Electrode transducer arrays, designed for use with its Optune Gio device, which is used in ...

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: A prospective, randomized, open label, single-center trial.

Ultrasonic levitation is by now a familiar trick: one or more ultrasonic transducers create a standing wave, and small ...

A prototype low-frequency speaker one-third the volume of a traditional subwoofer has been developed by Cupertino, CA, audio technology supplier Tymphany. Called a linear-array transducer (LAT), the ...

July 6 (UPI) --Northrop Grumman reports it has received a contract from the U.S. Navy to produce Transducer Array/Nose Shell Assemblies for MK 48 heavyweight torpedoes, the company announced on ...

The Vantage NXT system provides three encoder inputs that enable users to track position, movement, and rotation during data acquisition. Researchers can use encoder count data for Pulse-on-position ...

ROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved its new Head Flexible Electrode (HFE) transducer arrays for use ...